Logo image of SGTX

SIGILON THERAPEUTICS INC (SGTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:SGTX - US82657L2060 - Common Stock

22.47 USD
-0.59 (-2.56%)
Last: 8/10/2023, 8:02:09 PM
23 USD
+0.53 (+2.36%)
After Hours: 8/10/2023, 8:02:09 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to SGTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 48.28. This target is 114.86% above the current price.
SGTX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SGTX.
In the previous month the buy percentage consensus was at a similar level.
SGTX was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

SGTX Historical Analyst RatingsSGTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 22.4721.2130.6048.2895.55 - -5.61% 36.18% 114.86% 325.23%

Related screens

SGTX Current Analyst RatingSGTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-07-05 Canaccord Genuity Maintains Buy -> Buy
2023-07-03 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-06-30 BTIG Downgrade Buy -> Neutral
2023-06-30 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-26 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-25 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-01-18 Canaccord Genuity Initiate Buy
2021-12-23 Canaccord Genuity Maintains Buy
2021-12-01 Barclays Maintains Overweight
2021-11-30 Morgan Stanley Maintains Equal-Weight
2021-11-30 Jefferies Downgrade Buy -> Hold
2021-10-29 BTIG Initiate Buy
2021-07-19 Canaccord Genuity Maintains Buy
2021-07-16 Morgan Stanley Maintains Equal-Weight

SIGILON THERAPEUTICS INC / SGTX FAQ

What is the price target for SGTX stock?

9 analysts have analysed SGTX and the average price target is 48.28 USD. This implies a price increase of 114.86% is expected in the next year compared to the current price of 22.47.


What is the consensus rating for SIGILON THERAPEUTICS INC (SGTX) stock?

The consensus rating for SIGILON THERAPEUTICS INC (SGTX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover SIGILON THERAPEUTICS INC (SGTX) stock?

The number of analysts covering SIGILON THERAPEUTICS INC (SGTX) is 9.